301 related articles for article (PubMed ID: 21118985)
1. MicroRNA miR-125b causes leukemia.
Bousquet M; Harris MH; Zhou B; Lodish HF
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21558-63. PubMed ID: 21118985
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA.
Bousquet M; Nguyen D; Chen C; Shields L; Lodish HF
Haematologica; 2012 Nov; 97(11):1713-21. PubMed ID: 22689670
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPα (C/EBPα-C(m))-induced myeloid leukemia.
Enomoto Y; Kitaura J; Shimanuki M; Kato N; Nishimura K; Takahashi M; Nakakuma H; Kitamura T; Sonoki T
Int J Hematol; 2012 Sep; 96(3):334-41. PubMed ID: 22843432
[TBL] [Abstract][Full Text] [Related]
4. Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.
Enomoto Y; Kitaura J; Hatakeyama K; Watanuki J; Akasaka T; Kato N; Shimanuki M; Nishimura K; Takahashi M; Taniwaki M; Haferlach C; Siebert R; Dyer MJ; Asou N; Aburatani H; Nakakuma H; Kitamura T; Sonoki T
Leukemia; 2011 Dec; 25(12):1849-56. PubMed ID: 21738213
[TBL] [Abstract][Full Text] [Related]
5. Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A.
Chaudhuri AA; So AY; Mehta A; Minisandram A; Sinha N; Jonsson VD; Rao DS; O'Connell RM; Baltimore D
Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4233-8. PubMed ID: 22366319
[TBL] [Abstract][Full Text] [Related]
6.
Liu J; Guo B; Chen Z; Wang N; Iacovino M; Cheng J; Roden C; Pan W; Khan S; Chen S; Kyba M; Fan R; Guo S; Lu J
Blood; 2017 Mar; 129(11):1491-1502. PubMed ID: 28053194
[TBL] [Abstract][Full Text] [Related]
7. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia.
Zhang H; Luo XQ; Feng DD; Zhang XJ; Wu J; Zheng YS; Chen X; Xu L; Chen YQ
Mol Cancer; 2011 Sep; 10():108. PubMed ID: 21880154
[TBL] [Abstract][Full Text] [Related]
9. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.
Zhang X; Ren R
Blood; 1998 Nov; 92(10):3829-40. PubMed ID: 9808576
[TBL] [Abstract][Full Text] [Related]
10. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.
Bousquet M; Quelen C; Rosati R; Mansat-De Mas V; La Starza R; Bastard C; Lippert E; Talmant P; Lafage-Pochitaloff M; Leroux D; Gervais C; Viguié F; Lai JL; Terre C; Beverlo B; Sambani C; Hagemeijer A; Marynen P; Delsol G; Dastugue N; Mecucci C; Brousset P
J Exp Med; 2008 Oct; 205(11):2499-506. PubMed ID: 18936236
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice.
Chen Y; Hu Y; Michaels S; Segal D; Brown D; Li S
Leukemia; 2009 Aug; 23(8):1446-54. PubMed ID: 19322212
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-125b is required for normal B-cell development.
Li G; So AY; Sookram R; Wong S; Wang JK; Ouyang Y; He P; Su Y; Casellas R; Baltimore D
Blood; 2018 Apr; 131(17):1920-1930. PubMed ID: 29555645
[TBL] [Abstract][Full Text] [Related]
13. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D
Blood; 1998 Nov; 92(10):3780-92. PubMed ID: 9808572
[TBL] [Abstract][Full Text] [Related]
14. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
15. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
16. Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias.
So AY; Sookram R; Chaudhuri AA; Minisandram A; Cheng D; Xie C; Lim EL; Flores YG; Jiang S; Kim JT; Keown C; Ramakrishnan P; Baltimore D
Blood; 2014 Aug; 124(9):1502-12. PubMed ID: 25006123
[TBL] [Abstract][Full Text] [Related]
17. Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector.
Uchida N; Hanawa H; Dan K; Inokuchi K; Shimada T
J Nippon Med Sch; 2009 Jun; 76(3):134-47. PubMed ID: 19602820
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
[TBL] [Abstract][Full Text] [Related]
19. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
Klusmann JH; Li Z; Böhmer K; Maroz A; Koch ML; Emmrich S; Godinho FJ; Orkin SH; Reinhardt D
Genes Dev; 2010 Mar; 24(5):478-90. PubMed ID: 20194440
[TBL] [Abstract][Full Text] [Related]
20. miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20.
Liu Z; Smith KR; Khong HT; Huang J; Ahn EE; Zhou M; Tan M
Oncotarget; 2016 Nov; 7(48):78667-78679. PubMed ID: 27637078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
